Alere to Attend the 31st Annual J.P. Morgan Healthcare Conference on January 9, 2013

Fri Dec 28, 2012 4:06pm EST

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link

WALTHAM, Mass.,  Dec. 28, 2012  /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global
leader in enabling individuals to take charge of their health at home through
the merger of rapid diagnostics and health information technology, announced
today that it will attend the 31st  Annual J.P. Morgan Healthcare Conference
being held  January 7  - 10, 2013 at the Westin St. Francis Hotel in San
Francisco.  Ron Zwanziger, Chief Executive Officer, and  Jon Russell, Vice
President, Finance, will attend.  Mr. Zwanziger's presentation is scheduled for 
Wednesday, January 9, 2013  at  10:00 a.m. PST  and will be made available to
the public through a webcast accessible via, as
well as through the company's website at   

A replay of the webcast will be available via the links above for approximately
30 days from the date of the webcast.  During his presentation, Mr. Zwanziger
may discuss and answer questions concerning business and financial developments
and trends.  His responses to questions, as well as other matters discussed
during the webcast, may contain or constitute information that has not been
disclosed previously.

About Alere  
By developing new capabilities in near-patient diagnosis, monitoring and health
information technology, Alere enables individuals to take charge of improving
their health and quality of life at home. Alere's global leading products and
services, as well as its new product development efforts, focus on cardiology,
infectious disease, toxicology and diabetes. Alere is headquartered in  Waltham,
Massachusetts.  For more information regarding Alere, please visit   

SOURCE  Alere Inc.

Doug Guarino, Director of Corporate Relations, +1-781-647-3900
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.